Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Read runs and technical replicates

    So I've downloaded some example data from SRA archives at http://www.ncbi.nlm.nih.gov/sra?term=SRA011001 and had a question about technical and biological replicates (see attached picture for a snapshot of the downloads). I know that there are two biological replicates for control and treatment conditions (in this case a miR155 over-expression retrovirus) but I'm not sure about the technical replicates.

    Do read runs count as technical replicates?

    And, if so, how can I use that in my analysis pipeline (currently I'm using the Tuxedo suite (i.e. tophat > cufflinks > cuffmerge, etc.)).

    Right now I think I'm just telling the program that there are six biological replicates of each condition (i.e. 6 x miR155oe vs. 6 x control) which is probably wrong.

    Thanks, Scott
    Attached Files

  • #2
    It has been shown in many cases that Biological variation is far greater than technical variation in Illumina sequencing and typically individual runs are pooled together and treated as one sample. Ideally thats why you multiplex all your biological replicates and spread the sequencing across multiple lanes.

    Comment


    • #3
      Originally posted by chadn737 View Post
      It has been shown in many cases that Biological variation is far greater than technical variation in Illumina sequencing and typically individual runs are pooled together and treated as one sample. Ideally thats why you multiplex all your biological replicates and spread the sequencing across multiple lanes.
      Is there paper where this is shown?

      So perhaps I should merge my .sam files per biological replicate and then do the tophat/bowtie alignment?

      Thanks.

      Comment


      • #4
        Marioni, J. C., C. E. Mason, S. M. Mane, M. Stephens and Y. Gilad,
        2008 RNA-Seq: an assessment of technical reproducibility and
        comparison with gene expression arrays. Genome Res. 18: 1509–1517.

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Advancing Precision Medicine for Rare Diseases in Children
          by seqadmin




          Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...
          12-16-2024, 07:57 AM
        • seqadmin
          Recent Advances in Sequencing Technologies
          by seqadmin



          Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.

          Long-Read Sequencing
          Long-read sequencing has seen remarkable advancements,...
          12-02-2024, 01:49 PM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, 12-17-2024, 10:28 AM
        0 responses
        26 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 12-13-2024, 08:24 AM
        0 responses
        42 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 12-12-2024, 07:41 AM
        0 responses
        28 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 12-11-2024, 07:45 AM
        0 responses
        42 views
        0 likes
        Last Post seqadmin  
        Working...
        X